Valuation: PROCEPT BioRobotics Corporation

Market Cap 1.01B 885M 824M 757M 1.42B 96.56B 1.44B 9.79B 3.83B 47.68B 3.78B 3.7B 165B P/E 2026 *
-11.6x
P/E 2027 * -20.1x
Enterprise Value 1.01B 885M 824M 757M 1.42B 96.56B 1.44B 9.79B 3.83B 47.68B 3.78B 3.7B 165B EV / Sales 2026 *
2.53x
EV / Sales 2027 * 2.05x
Free-Float
96.83%
Yield 2026 *
-
Yield 2027 * -
1 day+5.99%
1 week-7.96%
Current month-21.66%
1 month-21.59%
3 months-26.57%
6 months-42.53%
Current year-43.77%
1 week 16.66
Extreme 16.665
18.53
1 month 16.66
Extreme 16.665
24.2
Current year 16.66
Extreme 16.665
35.4
1 year 16.66
Extreme 16.665
55.32
3 years 16.66
Extreme 16.665
103.81
5 years 15.38
Extreme 15.38
103.81
10 years 15.38
Extreme 15.38
103.81
Manager TitleAgeSince
Chief Executive Officer 60 2025-09-01
Director of Finance/CFO 48 2018-09-30
Chief Operating Officer 56 2026-02-28
Director TitleAgeSince
Chairman 74 2021-02-28
Director/Board Member 48 2015-05-31
Director/Board Member 50 2020-11-30
Date Insider Type Main position Quantity % Market Cap.
6/9/26 Free

Director

9,168 0.0161%
6/9/26 Free

Director

9,168 0.0161%
6/9/26 Free

Director

9,168 0.0161%
Change 5-day change 1-year change 3-year change Capi.($)
+5.99%-7.96%-68.25%-49.65% 1.01B
+1.39%+2.78%-17.43%-7.24% 182B
+1.21%+1.12%-9.38%-4.85% 108B
+0.41%+2.36%+7.16%+66.10% 60.54B
-4.21%-6.94%+21.43%+48.82% 50.53B
+1.64%+2.87%-14.25%-43.96% 43.79B
+2.45%+2.11% - - 33.57B
+2.56%-3.07%-17.55%-43.28% 28.31B
+0.93%-5.98%+25.71%-6.66% 23.31B
+2.02%+1.83%-5.23%-4.95% 21.28B
Average +1.52%-1.34%-8.64%-5.08% 55.22B
Weighted average by Cap. +1.07%+0.76%-6.49%+2.25%

Financials

2026 *2027 *
Net sales 397M 349M 325M 299M 561M 38.12B 568M 3.87B 1.51B 18.82B 1.49B 1.46B 65.05B 490M 431M 401M 369M 692M 47.04B 701M 4.77B 1.86B 23.23B 1.84B 1.8B 80.28B
Net income -86.02M -75.62M -70.39M -64.64M -121M -8.25B -123M -837M -327M -4.07B -323M -316M -14.08B -47.04M -41.36M -38.5M -35.35M -66.39M -4.51B -67.26M -458M -179M -2.23B -177M -173M -7.7B
Net Debt - -
Logo PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are advanced, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). It designed Aquablation therapy to deliver outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH that is independent of prostate size and shape and delivers resection independent of surgeon experience. It manufactures the robotic systems, the single-use disposable handpiece, integrated scope and other accessories at its facility in San Jose, California. Each robotic system is shipped to its customers with a third-party manufactured ultrasound system and probe.
Employees
888
Date Price Change Volume
26-07-27 US$17.69 +5.99% 1,344,446
26-07-24 US$16.69 -4.90% 1,886,448
26-07-23 US$17.55 -0.85% 1,532,620
26-07-22 US$17.70 -4.43% 1,138,190
26-07-21 US$18.52 -3.64% 1,129,878
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
17.69USD
Average target price
29.30USD
Spread / Average Target
+65.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PRCT Stock